PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 201 filers reported holding PORTOLA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2019 | $555,000 | -1.2% | 20,700 | 0.0% | 0.11% | 0.0% |
Q2 2019 | $562,000 | -21.7% | 20,700 | 0.0% | 0.11% | -23.0% |
Q1 2019 | $718,000 | +168.9% | 20,700 | +51.1% | 0.15% | +142.6% |
Q4 2018 | $267,000 | +0.4% | 13,700 | +37.0% | 0.06% | +13.0% |
Q3 2018 | $266,000 | -29.6% | 10,000 | 0.0% | 0.05% | -28.0% |
Q2 2018 | $378,000 | +55.6% | 10,000 | +100.0% | 0.08% | +53.1% |
Q4 2017 | $243,000 | -10.0% | 5,000 | 0.0% | 0.05% | -15.5% |
Q3 2017 | $270,000 | – | 5,000 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Grace Capital | 270,832 | $6,467,000 | 5.27% |
Fernwood Investment Management, LLC | 336,111 | $8,026,000 | 3.84% |
Tamarack Advisers, LP | 595,000 | $14,268,000 | 3.26% |
First Light Asset Management, LLC | 1,008,957 | $24,094,000 | 3.08% |
NEXPOINT ASSET MANAGEMENT, L.P. | 1,540,679 | $36,791,000 | 2.79% |
CADIAN CAPITAL MANAGEMENT, LP | 2,133,343 | $50,944,000 | 2.25% |
SECTORAL ASSET MANAGEMENT INC | 606,189 | $14,476,000 | 2.16% |
Asymmetry Capital Management, L.P. | 49,431 | $1,180,000 | 2.12% |
Parkman Healthcare Partners LLC | 275,505 | $6,579,000 | 1.90% |
HARVEY CAPITAL MANAGEMENT INC | 150,751 | $3,599,000 | 1.60% |